Official websites use. Share sensitive information only on official, secure websites. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The objective of this study is to assess the safety of treatment with vibration massage using a deep oscillation device and the effects on symptom severity and quality of life in patients with primary fibromyalgia syndrome FMS. Outpatients with FMS performed an observational prospective study with visits 2โ4 weeks after the last treatment control and after further 2 months follow-up.
Seventy patients At control visit, 41 patients Tolerability was rated as 1. In conclusion, deep oscillation massage is safe and well tolerated in patients with FMS and might improve symptoms and quality of life rather sustained. Fibromyalgia syndrome FMS is a persistent and disabling widespread pain condition accompanied by chronic fatigue, cognitive problems, sleep disturbance, depression, and anxiety [ 1 , 2 ]. The prevalence of FMS is 0.
Current evidence suggests that centrally augmented pain processing and deficiencies in descending central modulation play an important role in producing pain in FMS; they may also negatively influence sleep, mood, and level of alertness [ 7 ]. Although there is no specific peripheral tissue anatomy that characterizes fibromyalgia, this does not reduce the importance of peripheral nociceptive mechanisms [ 8 ]. Treatment of FMS is focused on alleviating pain and increasing functioning, as causal therapy is still not available.
Nonpharmacological treatments, in particular lifestyle-oriented intervention including patient education, aerobic or other physical exercise, and cognitive-behavior therapy, have yielded effect sizes and cost-benefit ratios comparable to medications [ 9 โ 11 ]. However, a number of challenges prevent the broader adoption of these interventions, such as low compliance and high dropout rates for exercise, loss of benefit at follow-up, if compliance is low, and a lack of availability of these interventions to many patients [ 11 , 12 ].
